References
- Slade T, Johnston A, Teesson M et al.The Mental Health of Australians 2: Report on the 2007 National Survey of Mental Health and Wellbeing. Department of Health and Ageing, Canberra, Australia (2009).
- Rapee RM, Schniering CA, Hudson JL. Anxiety disorders during childhood and adolescence: origins and treatment. Ann. Rev. Clin. Psychol.5, 311–341 (2009).
- Last CG, Hansen C, Franco N. Anxious children in adulthood: a prospective study of adjustment. J. Am. Acad. Child Adolesc. Psychiatry36(5), 645–652 (1997).
- Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst. Rev. (3), CD005170 (2009).
- James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst. Rev.1, 1–25 (2006).
- Otto MW, Mchugh K, Kantak KM. Combined pharmacotherapy and cognitive–behavioral therapy for anxiety disorders: medication effects, glucocorticoids, and attenuated treatment outcomes. Clin. Psychol. Sci. Pract.17, 91–103 (2010).
- Walkup JT, Albano AM, Piacentini J et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N. Engl. J. Med.359(26), 2753–2766 (2008).
- Cahill L, Le Gorski K. Enhanced human memory consolidation with postlearning stress: interaction with the degree of arousal at encoding. Learning Mem.10, 270–274 (2003).
- NICE. NICE Guidance. NICE, London, UK (2010).
- Walker DL, Davis M. The role of amygdala glutamate receptors in fear learning, potentiated startle, and extinction. Pharmacol. Biochem. Behav.71(3), 379–392 (2002).
- Norberg MM, Krystal JH, Tolin DF. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol. Psychiatry63, 1118–1126 (2008).
- Guastella AJ, Richardson R, Lovibond PF et al. A randomised controlled trial of D-cycloserine enhancement of exposure therapy for social phobia. Biol. Psychiatry63, 544–549 (2008).
- Storch EA, McKay D, Reid JM et al.D-cycloserine augmentation of cognitive–behavioral therapy: directions for pilot research in pediatric obsessive–compulsive disorder. Child Youth Care Forum39(2), 101–112 (2010).
- Byrne SP, Farrell LJ, Rapee RM. Using cognitive enhancers to improve the treatment of anxiety disorders in young people: examining the potential for D-cycloserine to augment exposure for child anxiety. Clin. Psychol.15, 1–9 (2011).
- Uher R. The implications of gene–environment interactions in depression: will cause inform cure? Mol. Psychiatry13(12), 1070–1078 (2008).